PETS

PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. It markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The Company offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Wall Street analysts forecast PETS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PETS is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Petmed Express Inc revenue for the last quarter amounts to 46.47M USD, decreased -21.95 % YoY.

Petmed Express Inc. EPS for the last quarter amounts to -0.56 USD, increased 124.00 % YoY.

Petmed Express Inc (PETS) has 173 emplpoyees as of December 16 2025.

Today PETS has the market capitalization of 61.33M USD.